Vestcor Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49M Buy
7,902
+61
+0.8% +$10.7K 0.04% 399
2025
Q4
$1.33M Sell
7,841
-1,353
-15% -$207K 0.04% 415
2025
Q3
$1.21M Sell
9,194
-2,614
-22% -$314K 0.04% 415
2025
Q2
$1.25M Buy
11,808
+6,969
+144% +$757K 0.04% 429
2025
Q1
$601K Buy
+4,839
New +$631K 0.02% 607
2024
Q2
Sell
-641
Closed -$77K 1215
2024
Q1
$77K Sell
641
-826
-56% -$101K ﹤0.01% 1132
2023
Q4
$180K Hold
1,467
0.01% 1012
2023
Q3
$190K Sell
1,467
-19
-1% -$2.53K 0.01% 1005
2023
Q2
$184K Sell
1,486
-1,044
-41% -$140K 0.01% 861
2023
Q1
$370K Hold
2,530
0.01% 703
2022
Q4
$403K Buy
2,530
+19
+0.8% +$2.79K 0.01% 711
2022
Q3
$335K Buy
2,511
+1,081
+76% +$164K 0.01% 782
2022
Q2
$223K Buy
1,430
+458
+47% +$70.5K 0.01% 885
2022
Q1
$151K Buy
972
+217
+29% +$31.5K 0.01% 1004
2021
Q4
$96K Sell
755
-143
-16% -$18.8K ﹤0.01% 1049
2021
Q3
$117K Sell
898
-120
-12% -$18.1K ﹤0.01% 976
2021
Q2
$181K Buy
+1,018
New +$176K 0.01% 904
2020
Q4
Sell
-457
Closed -$65K 1002
2020
Q3
$65K Hold
457
﹤0.01% 822
2020
Q2
$50K Buy
+457
New +$50.5K ﹤0.01% 773

Other funds holding JAZZ

Vestcor Inc's JAZZ Position: Q1 2026 in Review

Vestcor Inc increased its Jazz Pharmaceuticals (JAZZ) stake by 0.78% in Q1 2026, buying an estimated $10.7K and bringing the position to 7,902 shares worth $1.49M. The position accounts for 0.04% of the portfolio, ranked #399.

Vestcor Inc first reported a position in JAZZ in Q2 2020 and has held it in 19 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Vestcor Inc held 7,902 shares of Jazz Pharmaceuticals worth $1.49M as of Q1 2026.
  • Vestcor Inc bought 61 Jazz Pharmaceuticals shares in Q1 2026, an estimated $10.7K.
  • Jazz Pharmaceuticals made up 0.04% of Vestcor Inc's portfolio in Q1 2026, its #399 holding.
  • Vestcor Inc first reported a position in Jazz Pharmaceuticals in Q2 2020 and has held it in 19 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.